Financhill
Back

XTL Biopharmaceuticals Quote, Financials, Valuation and Earnings

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!
Sell
41

XTLB
XTL Biopharmaceuticals

Last Price:
1.88
Seasonality Move:
6.1%

7 Day Trial

ALL ACCESS PASS

$ 7

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade

XTL Biopharmaceuticals Price Quote

$1.88

XTL Biopharmaceuticals Key Stats

Sell
41
XTL Biopharmaceuticals (XTLB) is a Sell

Day range:
$1.82 - $2.04
52-week range:
$0.76 - $4.99
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
3.79%

Volume:
53.6K
Avg. volume:
76.5K
1-year change:
147.37%
Market cap:
$10.2M
Revenue:
$0
EPS:
$-0.03

How Much Does XTL Biopharmaceuticals Make?

Data Unavailable

Is XTL Biopharmaceuticals Growing As A Company?

Data Unavailable

XTL Biopharmaceuticals Stock Price Performance

What Is XTL Biopharmaceuticals 52-Week High & Low?

XTL Biopharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy XTL Biopharmaceuticals?

Is XTL Biopharmaceuticals Cash Flow Positive?

Data Unavailable

XTL Biopharmaceuticals Return On Invested Capital

Data Unavailable

XTL Biopharmaceuticals Earnings Date & Stock Price

XTL Biopharmaceuticals Competitors

XTL Biopharmaceuticals Dividend Yield

XTL Biopharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 30.00
Upside from Last Price: 1495.74%

Major Shareholders

  • How many XTLB shares are owned by institutional investors?
    295.1K XTLB shares are owned by institutional investors
  • How many XTLB shares are owned by insiders?
    0 XTLB shares are owned by insiders